國立虎尾科技大學 |

Molecular Mechanisms of Retina Pathology and Ways of its Correction

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Molecular Mechanisms of Retina Pathology and Ways of its Correction/ by Svetlana Trofimova.
作者:	Trofimova, Svetlana.
面頁冊數:	VI, 90 p. 17 illus., 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cell Biology. -
電子資源:	https://doi.org/10.1007/978-3-030-50160-0
ISBN:	9783030501600

Molecular Mechanisms of Retina Pathology and Ways of its Correction
Trofimova, Svetlana.

Molecular Mechanisms of Retina Pathology and Ways of its Correction[electronic resource] /by Svetlana Trofimova. - 1st ed. 2020. - VI, 90 p. 17 illus., 11 illus. in color.online resource.

Chapter 1. Literature review -- Chapter 2. Results of experimental studies of short peptides (cytogens) in ophthalmology -- Chapter 3. Results of the clinical study of short peptides (cytogens) in ophthalmology -- Conclusion.

This book discusses the pathology of the retina, and reviews current research on the use of cell replacement therapy and short peptides to restore functional activity in retinal neurons. As the book describes, pathologies of the retina, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, present a long-standing challenge in the practice of clinical ophthalmology. Modern treatment for these conditions, which lead to irreversible blindness, includes laser exposure, surgical intervention, and drugs. These treatments aim to reduce the risk of new complications in the eye; pathogenetic therapy of degenerative diseases of the retina is practically absent in current ophthalmic practice. The first section of the book reviews the molecular mechanisms of age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, and reports on methods of treatment. The second section presents the results of recent experimental studies of the effects of short peptides on pluripotent embryonic cells; on proliferative activity in retinal cells and pigment epithelium; on expression of markers of differentiation or retinal neurons and pigment epithelium; and on the course of hereditary retinal pigmentation in Campbell rats. The third section offers results of clinical studies on the effectiveness of short peptides in patients with macular degeneration, and in patients with retinitis pigmentosa. The author concludes that the regular use of peptides in the treatment of degenerative diseases of the retina can slow the progression of the pathological process and preserve the patient’s vision for some 10-15 years. In addition, in 80 percent of patients, it is possible to increase visual function by increasing visual acuity, improving the boundaries of the visual field and the fundus.

ISBN: 9783030501600

Standard No.: 10.1007/978-3-030-50160-0doiSubjects--Topical Terms:

593889
Cell Biology.

LC Class. No.: R-RZ

Dewey Class. No.: 610

Molecular Mechanisms of Retina Pathology and Ways of its Correction
LDR:03442nam a22003975i 4500 001 1023171
003 DE-He213
005 20200716124051.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030501600 $9 978-3-030-50160-0
024 7 $a 10.1007/978-3-030-50160-0 $2 doi
035 $a 978-3-030-50160-0
050 4 $a R-RZ
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 610 $2 23
100 1 $a Trofimova, Svetlana. $e author. $0 (orcid)0000-0002-5190-1824 $1 https://orcid.org/0000-0002-5190-1824 $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1319057
245 1 0 $a Molecular Mechanisms of Retina Pathology and Ways of its Correction $h [electronic resource] / $c by Svetlana Trofimova.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a VI, 90 p. 17 illus., 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Literature review -- Chapter 2. Results of experimental studies of short peptides (cytogens) in ophthalmology -- Chapter 3. Results of the clinical study of short peptides (cytogens) in ophthalmology -- Conclusion.
520 $a This book discusses the pathology of the retina, and reviews current research on the use of cell replacement therapy and short peptides to restore functional activity in retinal neurons. As the book describes, pathologies of the retina, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, present a long-standing challenge in the practice of clinical ophthalmology. Modern treatment for these conditions, which lead to irreversible blindness, includes laser exposure, surgical intervention, and drugs. These treatments aim to reduce the risk of new complications in the eye; pathogenetic therapy of degenerative diseases of the retina is practically absent in current ophthalmic practice. The first section of the book reviews the molecular mechanisms of age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, and reports on methods of treatment. The second section presents the results of recent experimental studies of the effects of short peptides on pluripotent embryonic cells; on proliferative activity in retinal cells and pigment epithelium; on expression of markers of differentiation or retinal neurons and pigment epithelium; and on the course of hereditary retinal pigmentation in Campbell rats. The third section offers results of clinical studies on the effectiveness of short peptides in patients with macular degeneration, and in patients with retinitis pigmentosa. The author concludes that the regular use of peptides in the treatment of degenerative diseases of the retina can slow the progression of the pathological process and preserve the patient’s vision for some 10-15 years. In addition, in 80 percent of patients, it is possible to increase visual function by increasing visual acuity, improving the boundaries of the visual field and the fundus.
650 2 4 $a Cell Biology. $3 593889
650 2 4 $a Geriatrics/Gerontology. $3 673757
650 1 4 $a Biomedicine, general. $3 1253757
650 0 $a Pharmacy. $3 582411
650 0 $a Cell biology. $3 1253486
650 0 $a Pathology. $3 668553
650 0 $a Ophthalmology. $3 644487
650 0 $a Geriatrics. $3 645067
650 0 $a Medicine. $3 644133
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030501594
776 0 8 $i Printed edition: $z 9783030501617
776 0 8 $i Printed edition: $z 9783030501624
856 4 0 $u https://doi.org/10.1007/978-3-030-50160-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)